Beautiful Virgin Islands

Tuesday, Jun 24, 2025

Complete Recovery Of Covid Patients May Take Longer Than 1 Year: Study

Complete Recovery Of Covid Patients May Take Longer Than 1 Year: Study

Coronavirus: The research on 1,276 patients from Wuhan, China, shows that around one in three people still experienced shortness of breath after 12 months.
Around half the people hospitalised with COVID-19 experience at least one persistent symptom up to 12 months after the infection, according to a study published in The Lancet journal on Friday.

The research on 1,276 patients from Wuhan, China, shows that around one in three people still experienced shortness of breath after 12 months, while lung impairments persisted in some patients, especially those who had experienced the most severe illness with COVID-19.

COVID-19 survivors were found to be less healthy than people from the wider community who had not been infected with the SARS-CoV-2 virus, which causes COVID-19.

"Our study is the largest to date to assess the health outcomes of hospitalised COVID-19 survivors after 12 months of becoming ill," said Professor Bin Cao, from China-Japan Friendship Hospital.

"While most had made a good recovery, health problems persisted in some patients, especially those who had been critically ill during their hospital stay," Cao said.

The study findings suggest that recovery for some patients will take longer than one year, and this should be taken into account when planning delivery of healthcare services post-pandemic.

A previous study by the same team on 1,733 hospitalised COVID-19 survivors found that around three-quarters of patients had persistent health problems after six months of infection.

The new study analysed data from patients who had been discharged from hospital between January 7 and May 29, 2020.

The patients underwent detailed health checks at six and 12 months to assess any ongoing symptoms and their health-related quality of life.

These included face-to-face questionnaires, physical examinations, lab tests, and a six-minute walking test to gauge patients'' endurance levels.

The average age of patients included in the study was 57 years. Patient outcomes were tracked for an average of 185 days and 349 days.

Many symptoms resolved over time, regardless of the severity of initial COVID-19 disease, the researchers said.

However, the proportion of patients still experiencing at least one symptom after one year fell from 68 per cent at six months to 49 per cent at 12 months, they said.

This decrease was observed regardless of the severity of COVID-19 the patients had experienced when hospitalised.

The study shows that fatigue or muscle weakness was the most commonly reported symptom with around half of patients experiencing this at six months, falling to one in five patients at one year.

Almost one third of patients reported experiencing shortness of breath at 12 months, which was slightly higher than at six months, according to the researchers.

This was more prevalent in patients who had been the most severely ill and had been on a ventilator during their time in hospital, compared to those who had not required oxygen treatment, they said.

At the six-month check, 349 study participants underwent a lung function test and 244 of those patients completed the same test at 12 months.

The proportion of patients experiencing diffusion impairment did not improve from six months to 12 months and this was seen across all groups regardless of how ill they had been when hospitalised.

Also at the six-month check, 353 study participants underwent a chest CT scan.

The researchers found that around one half of them showed lung abnormalities on their scan.

Of the 118 patients who completed the scan at 12 months, the proportion of patients with abnormalities decreased substantially across all groups but was still high, particularly in the most critically ill group, they said.

Compared with men, women were 1.4 times more likely to report fatigue or muscle weakness, twice as likely to report anxiety or depression, and almost three times as likely to have lung diffusion impairment after 12 months, according to the study.

People who had been treated with corticosteroids during the acute phase of their illness with COVID-19 were 1.5 times as likely to experience fatigue or muscle weakness after 12 months, compared to those who had not been treated during their illness.

The researchers found that slightly more patients experienced anxiety or depression at one year than at six months and the proportion was much greater in COVID-19 survivors than in matched people from the wider community.

"We do not yet fully understand why psychiatric symptoms are slightly more common at one year than at six months in COVID-19 survivors," said Xiaoying Gu, one of the study''s authors, from China-Japan Friendship Hospital.

"These could be caused by a biological process linked to the virus infection itself, or the body''s immune response to it. Or they could be linked to reduced social contact, loneliness, incomplete recovery of physical health or loss of employment associated with illness," Gu said.

The authors acknowledged that their study was focused on a single hospital and so patient outcomes may not be generalisable to other settings.

The study included only a small number of patients who had been admitted to intensive care and findings relating to the most critically ill patients should be interpreted with caution, they added.
Newsletter

Related Articles

Beautiful Virgin Islands
0:00
0:00
Close
Airlines Evaluate Flight Cancellations Amid Escalating US-Iran Tensions
Starmer Invites Innovators to Join Government Talent Scheme
UK Economy’s Strong Opening Quarter Shows Signs of Cooling
Harrods Seeks Court Order to Secure Al Fayed Estate for Victims
BA and Singapore Airlines Cancel Dubai Flights Amid Middle East Tensions
Trump Faces Backlash from MAGA Base Over Iran Strikes
Meta Bets $14 B on Alexandr Wang to Drive AI Ambitions
WATCH: Israeli forces show the aftermath of a massive airstrike at Iran's Isfahan nuclear site
FedEx Founder Fred Smith, ‘Heart and Soul’ of the Company, Dies at 80
Chinese Factories Shift Away from U.S. Amid Trump‑Era Tariffs
Pimco Seizes Opportunity in Japan’s Dislocated Bond Market
Labubu Doll Drives Pop Mart to Status as China’s Most Valuable Toy Maker
Global Coal Demand Defies Paris Accord Goals
We have new information and breaking details to share about what is shaping up to be a historic air campaign tonight
Six Massive Bombs Dropped on Fordow; Trump: 'A Historic Moment for the U.S., Israel, and the World'
Fordow: Deeply Buried Iranian Enrichment Site in U.S.–Israel Crosshairs
United States Conducts Precision Strikes on Iran’s Nuclear Sites
US strikes Iran nuclear sites, Trump says
Pakistan to nominate Trump for Nobel Peace Prize.
BBC Demands Perplexity AI Immediately Stop Using Its Content
Telegram Founder: I Will Leave My Fortune to Over 100 of My Children
Political Turmoil Resurfaces in Belgium Amid Economic Concerns
Fed policymakers divided on timing of interest rate cuts
Trump signals imminent agreement with Harvard University
Inheritance tax referendum alarms Swiss billionaire community
Japan cancels bilateral security meeting amid US defence demands
AI skeptic Emily Bender warns that ‘the emperor has no clothes’
Israel Confirms Assassination of Quds Force Commander in Tehran
16 Billion Login Credentials Leaked in Unprecedented Cybersecurity Breach
Senate hearing on who was 'really running' Biden White House kicks off
Iranian Military Officers Reportedly Seek Contact with Reza Pahlavi, Signal Intent to Defect
FBI and Senate Investigate Allegations of Chinese Plot to Influence the 2020 Election in Biden’s Favor Using Fake U.S. Driver’s Licenses
Vietnam Emerges as Luxury Yacht Destination for Ultra‑Rich
Plans to Sell Dutch Embassy in Bangkok Face Local Opposition
China's Iranian Oil Imports Face Disruption Amid Escalating Middle East Tensions
Trump's $5 Million 'Trump Card' Visa Program Draws Nearly 70,000 Applicants
DGCA Finds No Major Safety Concerns in Air India's Boeing 787 Fleet
Airlines Reroute Flights Amid Expanding Middle East Conflict Zones
Elon Musk's xAI Seeks $9.3 Billion in Funding Amid AI Expansion
Trump Demands Iran's Unconditional Surrender Amid Escalating Conflict
Israeli Airstrike Targets Iranian State TV in Central Tehran
President Trump is leaving the G7 summit early and has ordered the National Security Council to the Situation Room
Taiwan Imposes Export Ban on Chips to Huawei and SMIC
Israel has just announced plans to strike Tehran again, and in response, Trump has urged people to evacuate
Netanyahu Signals Potential Regime Change in Iran
Juncker Criticizes EU Inaction on Trump Tariffs
EU Proposes Ban on New Russian Gas Contracts
Analysts Warn Iran May Resort to Unconventional Warfare
Iranian Regime Faces Existential Threat Amid Conflict
Energy Infrastructure Becomes War Zone in Middle East
×